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Summary 
Dendritic cells, while effective in sensitizing T  cells to several different antigens, show little or 
no phagocytic activity. To the extent that endocytosis is required for antigen processing and 
presentation, it is not evident how dendritic cells would present particle-associated  peptides. Evidence 
has now been obtained showing that progenitors to dendritic cells can internalize particles, including 
Bacillus Calmette-Guerin (BCG)  mycobacteria. The particulates are applied for 20 h  to bone 
marrow cultures that have been stimulated with granulocyte/macrophage colony-stimulating 
factor (GM-CSF) to induce aggregates of growing dendritic cells. Cells within these aggregates 
are clearly phagocytic. If the developing cultures are exposed to particles, washed, and "chased" 
for 2 d, the number of major histocompatibility complex class II-rich dendritic cells increases 
substantially and at least 50% contain internalized mycobacteria or latex particles.  The mycobacteria- 
laden, newly developed dendritic cells are much more potent in presenting antigens to primed 
T cells than corresponding cultures of mature dendritic cells that are exposed to a pulse of organisms. 
A  similar situation exists when the BCG-charged dendritic cells are injected into the footpad 
or blood stream of naive mice. Those dendritic cells that have phagocytosed organisms induce 
the strongest T  cell responses to mycobacterial antigens in draining lymph node and spleen. 
The administration of antigens to GM-CSF-induced, developing dendritic cells (by increasing 
both antigen uptake and cell numbers) will facilitate the use of these antigen-presenting cells 
for active immunization in situ. 
T 
here is increased interest in the use of constituent pro- 
teins and peptides to modulate T cell responses to com- 
plex microbial and cellular antigens in situ. Typically, artificial 
adjuvants are required. Several antigens are known to be im- 
munogenic when administered in association with dendritic 
cells but in the absence of additional adjuvants (1). The im- 
munogenicity of dendritic cells in situ is apparent with con- 
tact allergens (2), transplantation antigens (3-6),  and more 
recently foreign proteins (7-9). The dendritic cells are serving 
directly as APCs in situ, because the T cells that are primed 
are restricted to recognize antigens presented by the MHC 
of the immunizing dendritic cells rather than host APCs (7, 
9). These observations, when coupled with data that den- 
dritic cells are efficient at capturing protein antigens in an 
immunogenic form in situ (10, 11, 12), make it apparent that 
these dendritic cells are "nature's  adjuvant" 
Dendritic cells offer the potential of processing complex 
antigens into those peptides that would be presented by self- 
MHC products. A possible restriction to this immunizing 
potential relates to the fact that in most species and tissues, 
dendritic cells are not actively phagocytic. Since endocytosis 
is an important means whereby antigens are processed to form 
the peptides that are presented on MHC  class  II products 
(13-15), it is not apparent how dendritic cells would present 
particle-derived peptides. The paradox is heightened by re- 
cent data that phagocytic macrophages do not appear to regur- 
gitate peptides for presentation by dendritic cells (12). 
Here we describe an apparent solution to this issue. We 
will show that dendritic cells can internalize particulates during 
an early stage in their development from proliferating pro- 
genitors. Prior work established that the stimulation of bone 
marrow suspensions with GM-CSF leads to the production 
of clusters of proliferating dendritic cell precursors (16). The 
cells that pulse label with [3H]thymidine in the clusters lack 
many of the characteristic markers of dendritic cells, e.g., stel- 
late shape and antigenic features like NLDC-145 antigen and 
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[3H]thymidine-labded progeny with all the features of den- 
dritic cells are released. We have found that cells within the 
aggregate also are phagocytic, and that in analogous pulse- 
chase protocols, the progeny dendritic cells are dearly labeled 
with the phagocytic meal.  When  the particles are Bacillus 
Calmette-Guerin (BCG) 1 organisms, mycobacterial antigens 
are presented in a potent manner to T cells in vitro and in situ. 
Materials and Methods 
Mice.  (BALB/c  x  DBA/2)F1, (C57BL/6  x  DBA/2)F1, and 
BALB/c male and female mice were purchased from the Trudeau 
Institute (Saranac Lake, NY) and Japan SIC (Hamamatsu,  Shizuoka) 
and used at 6-10 wk of age. 
Bone Marrow Culture.  As  described (16), bone marrow was 
flushed from the femurs and tibias, depleted of red cells with 0.83% 
ammonium chloride, and nonlymphoid la- cells were cultured in 
24-well plates (Nunc, NaperviUe, IL; and 25820; Coming Science 
Products, Rochester, NY) at 106 cells per well in 1 ml of RPMI 
1640 supplemented with 5% FCS, 20 #g/ml gentamicin, and 1,000 
U/ml  recombinant  murine GM-CSF  (9.7  x  107 U/mg;  Kirin 
Brewery, Maebashi,  Gumma, Japan). At 2 d, 0.75 ml of medium 
and most of the nonadherent cells were removed and replaced with 
fresh medium. This was repeated at days 4-5, thereby removing 
most of the developing granulocytes and leaving behind clusters 
of proliferating dendritic cells adherent to a stroma that included 
scattered macrophages. The culture medium was then supplemented 
with particulates,  and phagocytosis was  allowed  to proceed for 
20-24 h, usually on days 5-6. At this point the cultures were rinsed 
free of loose cells and particles,  and the cells were analyzed im- 
mediately for particle uptake. Alternatively, cells in the washed cul- 
tures were dislodged and 3-4  x  106 cells were transferred to a 60- 
ram petri dish for 1- or 2-d "chase" period in particle-free,  fresh, 
GM-CSF-supplemented medium. Class II-rich, mature dendritic 
cells developed during the chase as described (16), and these were 
isolated by cell sorting (below). To compare the phagocytic activity 
of developing and mature dendritic cells, particles  were also ad- 
ministered to 7-8-d bone marrow cultures that are rich in single 
nonproliferating mature dendritic cells. 
Particulates.  BCG  mycobacteria at  1.5-2.5  x  10  s  CFU/ml 
(Trudeau Institute) and 4  x  10  s CFU/ml (Kyowa Pharmaceutical 
Industries,  Tokyo, Japan) were administered  at ~107 live BCG per 
16-mm diameter well. Uptake was assessed following an "acid-fast" 
stain using an auramine-rhodamine procedure (17) that is more sen- 
sitive than Ziehl Neelsen and facilitates organism counts. Colloidal 
carbon (Pellikan Ink, Hannover, Germany) was added at 1:2,000 
dilution. The carbon was identified as a black granular stain in spec- 
imens stained with Diff-Quik  |  (Baxter Healthcare Corp., Miami, 
FL). Latex particles (0.5% [vol/vol], 2-#m diameter; Seradyn, In- 
dianapolis, IN) were applied to 1 ml of  culture in a 16-mm-diameter 
well at 50 #l/well. 
Isolation of Mature Dendritic Cells by Cell Sorting.  As noted be- 
fore (16), the dendritic ceils that are produced in GM-CSF-stimulated 
bone marrow cultures express very high levels of surface MHC class 
II products (mAbs B21-2; TIB 229, and M5/114; TIB 120 from 
the American Type Culture Collection [ATCC], Rockville, MD) 
as well as moderate levels of a dendritic cell-restricted antigen rec- 
ognized by mAb NLDC-145 (18). Immediately after the pulse with 
1 Abbreviations used in this paper: BCG, Bacillus Calmette-Guerin; PPD, 
purified protein derivative. 
BCG, or after an additional 2 d of "chase" culture, the cells were 
stained with biotin B21-2 and FITC-streptavidin  (Tago, Burlingame, 
CA). Class II-rich cells then were sorted (FACStar Plus|  Becton 
Dickinson Immunocytometry Systems, San Jose, CA) and cytospun 
onto glass slides (Shandon Southern Instruments Inc,, Sewickley, 
PA). Sorted cells were stained with Diff-Quick  |  (Baxter Health- 
care Corp.), which outlines the stellate shape of dendritic cells in 
cytospins and allows enumeration of profiles containing perinuclear 
depots of internalized colloidal carbon or latex spheres. To visualize 
BCG, the cytospins were fixed in absolute acetone for 10 rain at 
room temperature and stained with M5/114 anti-class II, NLDC- 
145 anti-dendritic cell (18), or RA3-6B2 anti-B220 or anti-B cell 
(the latter as a control) followed by POX-conjugated mouse anti-rat 
Ig (Boehringer Mannheim Biochemicals, Indianapolis,  IN) and di- 
aminobenzidine tetraHC1 (Polyscience Inc., Warrington, PA). The 
preparations were then double labeled for acid-fast bacilli with aura- 
mine rhodamine (17). Virtually all the cells in the preparation were 
rich in NLDC-145 and MHC class II products. The numbers of 
BCG bacilli  in at least 400 cells were enumerated. 
Electron Microscoff/(EM).  To prove that cell-associated BCG were 
all internalized,  the dendritic cells produced in pulse-chase protocols 
(above) were fixed in 2.5% glutaraldehyde and processed for EM 
as described (16). 
Antigen  Presentation In  Vitro.  Mice were primed with  CFA 
(Sigma Chemical Co., St. Louis, MO), 25 #1 in the fore and rear 
paws,  or, as a control, mycobacteria-free IFA.  1-2 wk later,  the 
draining lymph nodes were dissociated  into a single-cell  suspen- 
sion and depleted of APCs with mAbs to MHC class II, B220, 
and heat-stable antigens (M5/114 anti-Ia, RA3-6B2 anti-B220, and 
Jlld anti-HSA; TIB 120, 146, and 183 from the ATCC, respec- 
tively) and rabbit complement. 3  x  10  s of these APC-depleted, 
primed T  cells were cultured in 96-well flat-bottomed microtest 
wells  (Nunc;  or  25860;  Corning  Science  Products) in  Click's 
medium (Irvine Scientific, Santa Ana, CA) supplemented with 0.5% 
normal mouse serum, 20 #g/ml gentamicin, 50 #M 2-ME, 2 mM 
glutamine, and 1 mM sodium pyrnvate (Gibco Laboratories, Grand 
Island, NY). Graded doses of BCG-pulsed, bone marrow or spleen 
APCs  were  added  (see  Results).  1 #Ci  of [3H]thymidine  (20 
Ci/mmol, 4 #Ci/ml; New England Nuclear, Boston, MA; or 15 
Ci/mmol, 4 #Ci/ml; American Radiolabeled Chemicals Inc., St. 
Louis, MO) was added to monitor DNA synthesis  at times indi- 
cated in the legends. Data shown are means of triplicates in which 
SDs were <15%  of the mean. 
Antigen Presentation In Viv~  APCs that had been pulsed with 
antigen in vitro were administered in vivo to unprimed (CxD2)Fj 
mice. To prime T cells in draining lymph node, 2  x  1@ dendritic 
cells were injected into the paws and node cell suspensions  were 
prepared 5 d later (7). To prime T  cells in spleen,  10  ~ cells were 
injected intravenously and splenocytes were prepared 5 or 10 d later. 
To measure T cell priming, bulk lymph node or spleen cells were 
cultured as above and challenged with  graded doses  of protein 
antigens, either purified protein derivative (PPD; Statensernm In- 
stitute,  Copenhagen,  Denmark,  or Dr.  Ichiro Toida,  Research 
Institute for BCG in Japan, Kiyose, Tokyo), or BSA, and [3H]thy- 
midine uptake was measured at 48-64 h. To characterize the pro- 
liferating cells, the populations were treated with antibodies and 
complement before measuring [3H]thymidine uptake. 
Results 
Phagocytosis of Latex Particles within Clusters  of Developing 
Dendritic Cells: Pulse and Pulse-Chase Protocols.  When mouse 
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ating  cell aggregates  appear,  and  these  give rise  to  large 
numbers of typical immunostimulatory dendritic cells (16, 
19).  In bone marrow, which was used for the experiments 
described below, the proliferating aggregates are best identified 
by washing away the majority of nonadherent granulocytes 
that are also  induced by GM-CSF in the cultures (16).  At 
days 5-6, the time point when the aggregates were first siz- 
able (5-10 cells wide), we applied different particles over a 
20-22-h  period. 
After administration of 2-/zm latex spheres, heavy labeling 
was noted in scattered macrophages on the monolayer. In 
addition, some clear labeling occurred within the developing 
dendritic cell aggregates (Fig. 1 A). Aggregates that had been 
exposed to particles were recultured an additional 2 d. During 
this time, large numbers of cells were released into suspen- 
sion. These primarily were mature dendritic cells with char- 
acteristic stdlate shapes and high levels of MHC dass II and 
NLDC-145 antigens (16). When the released cells were ex- 
amined by light microscopy, many contained latex spheres 
that were often around a clear perinuclear zone or centrosphere 
(Fig. 1 B). We also studied colloidal carbon uptake in a similar 
manner. When aggregates were pulsed with colloid and ma- 
ture dendritic cells were allowed to form during a chase period, 
some of the released cells had a centrosphere with small but 
clear-cut carbon deposits (Fig.  1 C). In contrast, when latex 
or carbon was offered to mature dendritic cells, little uptake 
took place (Fig.  1 D). 
BCG Uptake by Developing Dendritic Cells: Acid-fast Stains. 
The same protocols were repeated, but now preparations with 
live BCG mycobacteria were administered as the phagocytic 
meal.  Cell-associated bacilli  were visualized by a  sensitive 
fluorescent acid-fast stain. After the 20-h pulse, the developing 
dendritic cell aggregates were again strongly labeled. To iso- 
Figure  1.  Diff-Quick  stains of developing dendritic  cells that have been exposed to Latex and carbon.  (A) An aggregate of developing dendritic 
cells cytospun  after a 20-h exposure to 2-/zm latex spheres. Many cells in the aggregate are labeled with the uniform latex particles (arrows).  x 270. 
(B) Same as A, but the cultures were chased for 1 d to allow the production of mature single dendritic  cells. Many of the released dendritic  cells 
contain the uniform and lucent latex spheres (arrows).  x675. (C) Same as A  and B, but the aggregates were pulsed with colloidal carbon and then 
chased for 1 d in carbon-free medium. The centrospheres of some of the mature dendritic cells that release from the aggregate contain small but clear-cut 
endocytic granules of  black, indigestible phagocytic tracer (arrows). ￿ 675. (D)  Mature dendritic cells were exposed to carbon after they had been produced 
from proliferating  aggregates. Few if any carbon deposits are evident.  ￿ 
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resuspended the cells and sorted those with high levels  of 
MHC class II products. Immediately after the BCG pulse, 
,,o20% of the sorted cells contained acid-fast bacilli (Table 
1).  It was difficult to separate the majority of MHC  class 
II-weak cells because of excessive stickiness during cell sorting. 
Companion cell cultures were then studied after 2 d  of 
a chase culture. Because many mature dendritic cells formed 
during the chase period, the number of Ia-rich progeny had 
increased fourfold (Table 1).  About 50%  of these progeny 
contained BCG,  usually in a perinudear location (Table 1 
and Fig. 2). Double labeling experiments verified that the 
cells containing acid-fast bacilli expressed MHC class II and 
the dendritic cell-restricted NLDC-145 antigen (Fig. 2). Be- 
cause the total number of MHC class II- and NLDC-145- 
positive cells had also increased fourfold in just 2 d, it is likely 
the these BCG-laden dendritic cells were derived from less 
mature but phagocytic progenitors in the aggregates. 
Electron Microscotv of BCG-pulsed APCs.  The perinuclear 
location of the cell-associated particles by light microscopy 
indicated that organisms had been internalized. The matter 
was verified by dectron microscopy. Most of BCG organisms 
were identified intracellularly. All call-associated BCG were 
identified within intracellular vacuoles dose to the Golgi com- 
plex (Fig. 3, A and B). Typically only one or two badlli could 
be identified within any one section through the dendritic 
Table  1.  Frequency of Dendritic Cells with Phagocytosed BCG 
Organisms in GM-CSF-stiraulated Mouse Bone Marrow Cultures 
BCG  No. of  Phagocytic 
Exp.  exposure  cells counted  cells  BCG/DC 
% 
1  Days 5-6 pulse  469  18.1  2.6 
498  18.5  2.5 
2  Days 5-6 pulse  444  22.5  3.0 
463  22.2  2.9 
Pulse,  2-d chase  564  57.1  3.8 
579  57.0  3.2 
3  Days 5-6 pulse  440  21.8  2.1 
623  22.8  2.9 
Pulse,  2-d chase  487  50.3  2.9 
511  58.7  4.0 
Quantitative data of dendritic  cells containing BCG. Mouse bone mar- 
row cultures  were stimulated  in 16-mm wells for 5 d with GM-CSF, 
washed,  and exposed  to BCG organisms  for 20 h.  The cultures  were 
washed again and either examined immediately, or pooled and transferred 
to a 60-mm dish for an additional  2-d chase culture. The dendritic  cells 
in the cultures  were selected as h-rich cells using a cell sorter and then 
spun onto glass slides for staining  for acid-fast bacilli. During the chase 
period, the percentage of h-rich cells in the cultures increased 2-2.5-fold, 
and the total number of cells increased twofold, so that the number of 
h-rich cells increased four to five times. 
cell centrosphere. It appeared that a phagosomal membrane 
closely approximated most bacilli (Fig. 3  C  and D). 
Presentation In Vitro of Mycobacterial Antigens to Primed  T 
Cells.  To test the presenting function of dendritic cells that 
had been pulsed or pulse chased with BCG organisms, we 
first prepared antigen-responsive T  cells from the draining 
lymph nodes of mice that had been injected with CFA that 
contains heat-kiUed mycobacteria or with IFA as control (see 
Methods). When dendritic cells were added to IFA-primed 
T cells, a syngeneic mixed leukocyte reaction was observed. 
This was comparable whether or not the APCs had been ex- 
posed to BCG (Fig. 4, right). However, when dendritic cells 
had been pulsed with BCG and were added to CFA-primed 
T  cells, strong proliferative responses were induced (Fig. 4, 
left). If dendritic cells were tested immediately after the 1-d 
pulse, or after an additional 2-d chase period, the chased popu- 
lation was much more potent (Fig. 4, left, compare diamonds 
with inverted triangles). As few as 100 BCG pulse-chased den- 
dritic cells elicited sizable T  cell responses in vitro (Fig. 4 
left, diamonds). The BCG-pulse-chased populations also were 
5-10 times more potent in inducing responsiveness to mycobac- 
terial antigen than mature dendritic cells freshly exposed to 
either PPD or BCG (Fig. 4, left, compare diamonds with circles 
and triangles). Therefore, it appeared that the extent of phago- 
cytosis correlated with the efficacy of presentation, as the pulse- 
chased populations were the most active APCs and contained 
the most intracellular BCG  (Table 1). 
Presentation In Vivo of  MFobacterial Antigens to Unsensitized 
Mice.  Comparable populations of BCG-pulsed, and BCG- 
pulsed and chased, APCs were tested for the capacity to present 
mycobacterial antigens to unprimed mice. After injection into 
the footpads, strong responsiveness to PPD was observed (Fig. 
5). Again, the dendritic cells were the most potent if tested 
after a 2-d chase (Fig. 5; compare open diamonds with open 
triangles), and this chase period greatly increased the total yidd 
of dendritic cells (16). 
To test if the increased antigen-presenting function of BCG 
pulse-chased dendritic cells was related to the increased number 
of APCs carrying BCG,  the primed populations were also 
tested for responsiveness to BSA, since the dendritic cells had 
been grown in the presence of FCS.  All the dendritic cell 
populations, regardless of the details of the exposure to BCG, 
primed mice similarly to BSA (Fig.  5, filled symbols).  This 
indicates that each population was comparably ef~cient in 
immunizing to a soluble protein, whereas the dendritic cells 
that had phagocytosed BCG were more effective in eliciting 
responses to mycobacterial antigens. 
The surface markers of the primed cells  were tested by 
antibody- and complement-mediated lysis of the populations 
before measuring [3H]thymidine uptake (data not shown). 
The proliferating cells were Thy-1, but negative for MHC 
class II, heat-stable antigen, and B220. Anti-CD4 hybridoma 
culture  supernatant  blocked proliferation  ~>85%, i.e.,  the 
primed cells were Th cells. 
Priming was also observed when spleen T cells were tested 
after  an  intravenous  infusion  of  BCG-pulsed  and  BCG 
pulse-chased dendritic cells (Fig.  6).  The cells were more 
482  Dendritic Cell Progenitors  Phagocytose  Bacillus Calmette-Guerin Figure 2.  Uptake of BCG into developing dendritic cells using two-color labels for acid-fast bacilli and dendritic cell antigens. Clusters of developing 
dendritic ceils (6-d marrow cultures induced with GM-CSF) were exposed for 20 h to BCG.  The monolayers were washed and chased in medium 
with GM-CSF for 2 d. The cells were dissociated, hbded with FITC-anti-I-A mAb, and the class II-rich cells were isolated by cell sorting (most 
of the ceils in the culture are class II rich) as shown previously (16). The sorted ceils were cytospun,  stained with auramine-thodamine to visualize 
the cell-associated  BCG (B and D), and double labded with a different mAb and immunoperoxidase (,4 and C). Arrows on the left indicate the location 
of the bacilli. The peroxidase label for anti-class II (I-A and I-E, M5/114) outlines the dendritic cell processes (C) much better than the label for the 
dendritic  cell-restricted  NLDC-145  antigen (.4). The brown reaction product in the color version of A  corresponds to the dense black deposits in 
the black and white version that is shown,  x600. 
responsive at 5 vs.  10 d after injection (compare Fig. 6, A 
with  C).  Again  dendritic  cells that  had  been  cultured 
("chased") for 2 d after exposure to BCG were the most po- 
tent (Fig. 6, compare filled diamonds with filled triangles), but 
all populations primed the spleen cells similarly to BSA (Fig. 
6 B). We conclude that dendritic cell progenitors capture and 
retain mycobacterial antigens in a manner that is highly im- 
munogenic in vivo. 
Discussion 
Particle uptake is a specialized activity of mononuclear and 
polymorphonudear phagocytes.  Dead cells, immune com- 
plexes, and microorganisms all are avidly internalized.  After 
fusion with hydrolase-rich lysosomes, the ingested particles 
are degraded (20, 21). This degradation must be at the level 
of permeable amino acids (22, 23) and saccharides, otherwise 
the vacuolar apparatus would swell with indigestable materials 
(24,  25). Such dearance and digestive functions of phago- 
cytes contribute to wound healing,  tissue remodeling, and 
host defense. 
Another consequence of endocytosis, the processing of an- 
tigens by APCs differs in many respects from the scavenging 
function of phagocytosis. (a) Processing required the genera- 
tion of peptides at least 8-18 amino acids in length (26, 27), 
while scavenging entails digestion to amino acids (22, 23). 
(b) Presentation  requires the binding of peptides  to MHC 
class II products, possibly preferentially to newly synthesized 
class II (28, 29), whereas scavenging does not require MHC 
products.  (c) Antigen presentation  can function at a low ca- 
pacity,  since only a few hundred molecules of ligand need 
to be generated for successful  stimulation of  certain T-T hybrids 
(30,  31) and most likely primary T  cell populations  (32). 
During  scavenging,  phagocytes  readily  clear  and  destroy 
hundreds of thousands of protein molecules each hour (23). 
(d) Antigen presentation  is best carried out by cells that are 
rich in MHC class II but show little phagocytic activity and 
few lysosmes, i.e., dendritic cells and B cells, whereas phago- 
cytes (macrophages and neutrophils)  often have  low levels of 
class II and abundant lysosomes. These observations, together 
with the identification of antigenic specializations within the 
endocytic system of dendritic cells and B cells (33, 34), have 
483  Inaba et al. Figure 3.  Electron  microscopy  of BCG in dendritic cells. As in Fig. 2, BCG was added to GM-CSF-stimulated  6-d bone marrow cultures for I d. 
After washing and an additional 2 d of culture, the released cells were processed  for electron microscopy. (A and B) Low-power  views to show the 
typical dendritic cells with numerous processes  and a few phagocytosed  BCG (white arrows), x 5,400 (A); x 3,900 (B). (C and D) Higher power views 
to show phagosomal membranes against the BCG, as well as organelles of the dendritic cell centrosphere, including endocytic vacuoles (E), Golgi 
apparatus (GA),  and small vesicles with a dense core (A).  x20,000 (C); x15,000 (D). 
led to the suggestion that the machinery required for antigen 
presentation  may differ from that  required  for scavenging, 
both quantitatively and qualitatively (7). Nevertheless, how 
do APCs that are not phagocytic (B cells and dendritic cells) 
present  peptides derived from particulates? 
In the case of dendritic cells,  there have been indications 
that these APCs are at some point capable of phagocytic ac- 
tivity.  Pugh et al.  (35) noted Feulgen-stained inclusions in 
some afferent lymph dendritic cells and suggested that phago- 
cytosis of other cells  had taken place before entry into  the 
lymph (35). Fossum and Rolstad (36) noted phagocytic in- 
clusions in  the interdigitating  dendritic  cells  of the  T  cell 
areas in mice that were rejecting allogeneic leukocytes. Reis 
e Sousa et al. (37) found that freshly isolated epidermal Lang- 
erhans cells, which are immature but nonproliferating  den- 
dritic cells, can internalize small amounts of certain particu- 
lates. Here we show that clear-cut phagocytosis occurs when 
particles are administered to cultures of proliferating dendritic 
cells.  If particles are fed to progenitor populations,  phago- 
cytic activity is expanded both qualitatively, i.e.,  many den- 
dritic cell progeny carry a particulate meal, and quantitatively, 
i.e.,  the  numbers  of such cells are greatly increased. 
The number of particles ingested by developing dendritic 
cells is small relative to typical phagocytes,  and the rate of 
uptake is slow. For example,  after a 4-h pulse there is rela- 
tively little labeling  of dendritic  cell precursors  in  the de- 
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Figure  4.  Antigen presentation  to CFA-primed/ 
IFA-primed T cells. T cells were purified from lymph 
nodes that drain paws that had been primed with CFA 
or IFA. The different APCs are listed.  Mature den- 
dritic cells are day 8 bone marrow cultures,  and im- 
mature dendritic  cells are from day 5-6 cultures. 
veloping aggregates,  while there is active uptake by macro- 
phages on the monolayer. Nonetheless, the administration 
of particulate meals (latex and BCG) to developing cultures 
leads to clear-cut  phagocytosis by these specialized APCs. 
Some sense of the immunogenicity of the ingested parti- 
cles was obtained with BCG mycobacteria (Figs. 4-6).  In 
any  inoculum of the BCG  vaccine,  there  are  live bacilli 
(•50%  of the bacilli act as CFU), dead bacilli, and probably 
a  number of mycobacterial  proteins. We suspect  that the 
phagocytosed pool of BCG is being presented because of ob- 
servations comparing the presentation of mycobacterial  an- 
tigens with BSA, a component of the serum in which the 
dendritic cells are grown. Whereas dendritic cells that are 
pulsed and chased with BCG are the most effective APCs 
for mycobacteria (Figs. 5 and 6, diamonds) and contain the 
most particles, all the APC populations were comparable in 
presenting BSA. This implies that BCG particle uptake ac- 
counts for the bulk of the mycobacterial priming. One can 
now undertake a study wherein dendritic cells are evaluated 
for their capacity to induce host resistance to mycobacteria 
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Figure  5.  Antigen  presentation  to  naive 
node T cells in situ. Growing cultures of bone 
marrow dendritic cells were pulsed with BCG 
at days 5-6, and used immediately or after a 
2-d chase culture. The populations were injected 
into the paws of naive mice without artificial 
adjuvants. 5 d later the draining lymph nodes 
were taken and stimulated in vitro with graded 
doses of PPD and BSA (the dendritic cells had 
been grown with FCS), with the BSA serving 
as a nonparticuhte  antigen. Data are means and 
SDs  for  groups  of five mice,  each  studied 
separately. Control lymph nodes did not re- 
spond  to PPD or to BSA (<2,000  cpm). ￿9  unpulsed mature DC 
*  Immature, BCG-pulsed {add BCG to  growing  d5-6  aggregates) 
*,  Mature, BCG-pulsed (add BCG d7-8) 
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Figure  6.  Antigen  presentation 
to naive  spleen  cells  in situ. Growing 
cultures of bone marrow dendritic 
cells were  pulsed  with BCG at days 
5-6 (immature), at days 7-8 (ma- 
ture), or at days 5-6 followed  by a 
2-d chase. 106 cells were injected 
intravenously  into groups of mice. 
5 or 10 d later, the spleen  cells  were 
cultured  in vitro with graded  doses 
of  PPD or BSA as antigen.  Since  the 
dendritic  cells  were  cultured  in FCS, 
the use of BSA serves  as control  to 
ensure that all dendritic  cell popu- 
lations were comparably  immuno- 
genic  in vitro. Unprimed  spleen  did 
not respond  to either  BSA or PPD. 
infection, a matter of some import given the need to develop 
better vaccination and treatment protocols for tuberculosis, 
including the drug-resistant variety. 
In effect, the pulse and chase protocol that we have used 
to charge developing dendritic cells with organisms in the 
BCG  vaccine  allows  the  two  broad  components  of im- 
munostimulation to take place sequentially. These compo- 
nents are: (a) antigen capture and presentation, here the cap- 
ture of particulates,  by immature dendritic cells;  and  (b) 
development of potent accessory or immunostimulatory func- 
tions during the chase period. The situation is comparable 
to that seen in the handling of soluble proteins (29, 38) and 
particles (37) by epidermal Langerhans cells. Each of the two 
broad components of APC function entails many subcom- 
ponents. For example, immature dendritic ceUs not only are 
more phagocytic but display other features needed for an- 
tigen presentation such as active biosynthesis of abundant 
MHC class II molecules and invariant chain (29,  39)  and 
numerous acidic endocytic vacuoles (40). 
The capacity to charge APCs with antigens in pulse-chase 
protocols may be a spedal feature of dendritic cells. Prior studies 
with macrophages and B cells had suggested that T cell epi- 
topes are short lived (41). The results reported here and else- 
where (7,  29, 32) indicate that immunogenic peptides can 
be long lived on dendritic cells at least 2 d before injection 
into mice. This retention capacity should enable dendritic 
cells to migrate and sensitize T  cells in draining lymphoid 
tissues over a several-day  period (7-9). 
In this paper bone marrow was used as a ready source of 
GM-CSF-responsive, proliferating dendritic cell precursors 
(16). Similar progenitors are found in many other tissues (Inaba 
et al., manuscript in preparation) and in the blood itself (19). 
If progenitors are widely distributed, dendritic cells may ac- 
quire particulates whenever and wherever their proliferation 
and/or maturation is induced. The host may thereby generate 
in vivo sizable numbers of potent APCs that have success- 
fully processed particulate antigens in that locale. 
In  the case  of BCG,  the bulk  of the primed cells  are 
CD4 + T cells, most likely because the antigenic load is han- 
dled by the endocytic pathway and MHC class II products 
(15). An important feature of dendritic cells is the capacity 
to efficiently present microbial and other antigens on both 
class I and II products. In the case of influenza, it has been 
found that the class I pathway for inducing CD8 + CTL re- 
quires adequate delivery of antigen (infectious virus) into the 
cytoplasm, whereas the purely endocytic pathway delivers 
noninfectious virions for presentation to CD4 + helpers (42). 
Developing dendritic cell cuhures provide an opportunity for 
charging MHC class I products with peptide, since ceU prolifer- 
ation  allows various  methods of gene insertion  (as  with 
retroviral vectors) to be applied. 
By using developing dendritic cells to charge MHC class 
I and/or II products, several desirable components of T call 
modulation in situ can be achieved. One brings about an- 
tigen uptake and presentation with immature progenitors, 
allows the APC to tailor the peptides that are appropriate 
for an individual's MHC products, and increases the numbers 
of specialized  stimulatory APCs.  These properties of den- 
dritic cell progenitor populations meet many of the demands 
for using cells as vehicles for active immunization and im- 
munotherapy in situ. 
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